# Pacific Biosciences (PACB) — Analyst Forecast

PACB · NASDAQ · Stock

Canonical page: https://www.lighthorse.io/tickers/pacb/forecast

## Recent analyst ratings

| Date | Firm | Action | Rating | Price target |
| --- | --- | --- | --- | --- |
| Sep 9, 2026 | UBS | Initiated Coverage | Neutral | $1.35 |
| May 11, 2026 | Barclays | Maintained | Underweight | $1.50 |
| Apr 14, 2026 | Barclays | Maintained | Underweight | $1.00 |
| Mar 6, 2026 | Barclays | Downgraded | Equal-Weight → Underweight | $1.50 |
| Dec 15, 2025 | Barclays | Maintained | Equal-Weight | $2.00 |
| Nov 11, 2025 | Piper Sandler | Maintained | Neutral | $2.00 |
| Nov 10, 2025 | Stephens & Co. | Maintained | Overweight | $2.00 |
| Aug 11, 2025 | Piper Sandler | Maintained | Neutral | $1.50 |
| Jun 25, 2025 | Barclays | Maintained | Equal-Weight | $1.50 |
| May 15, 2025 | Stephens & Co. | Maintained | Overweight | $1.80 |
| May 15, 2025 | Piper Sandler | Maintained | Neutral | $1.25 |
| Apr 10, 2025 | Canaccord Genuity | Maintained | Buy | $3.00 |
| Mar 25, 2025 | Scotiabank | Maintained | Sector Outperform | $2.00 |
| Feb 20, 2025 | Piper Sandler | Maintained | Neutral | $2.00 |
| Feb 18, 2025 | Stephens & Co. | Maintained | Overweight | $2.50 |
| Feb 18, 2025 | Goldman Sachs | Maintained | Neutral | $1.50 |
| Feb 14, 2025 | Stephens & Co. | Maintained | Overweight | $2.50 |
| Jan 23, 2025 | Goldman Sachs | Maintained | Neutral | $1.75 |
| Nov 11, 2024 | Piper Sandler | Maintained | Neutral | $2.50 |
| Nov 11, 2024 | Scotiabank | Maintained | Sector Outperform | $6.00 |

## Frequently Asked Questions

### What is the latest analyst rating on PACB?

On Sep 9, 2026, UBS initiated coverage of Pacific Biosciences at Neutral with a price target of $1.35.

## Similar Stocks

- [TXG](https://www.lighthorse.io/tickers/txg) — 10x Genomics, Inc. - Common Stock

---

Analyst ratings and price targets are the opinions of third-party research firms, not of Light Horse Securities. They are estimates about an uncertain future, are frequently wrong, and are neither a recommendation nor a prediction of actual results.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.

Data provided by [AInvest](https://www.ainvest.com).